We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+8.64%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.66B
AUM Growth
+$133M
Cap. Flow
-$36.5M
Cap. Flow %
-1.38%
Top 10 Hldgs %
20.94%
Holding
3,322
New
317
Increased
715
Reduced
701
Closed
212

Sector Composition

Rank Sector Weight
1 Technology 19.84%
2 Industrials 10.47%
3 Consumer Discretionary 10.03%
4 Healthcare 8.76%
5 Financials 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLRX icon
1701
Pliant Therapeutics
PLRX
$66.3M
$84.5K ﹤0.01%
+4,666
New +$110K
IMVT icon
1702
Immunovant
IMVT
$8.64B
$84.5K ﹤0.01%
4,456
+1,315
+42% +$24.5K
RXRX icon
1703
Recursion Pharmaceuticals
RXRX
$1.69B
$84.2K ﹤0.01%
11,270
+1,129
+11% +$7.9K
STC icon
1704
Stewart Information Services
STC
$2.08B
$84.2K ﹤0.01%
2,046
ESRT icon
1705
Empire State Realty Trust
ESRT
$822M
$84K ﹤0.01%
11,214
JBSS icon
1706
John B. Sanfilippo & Son
JBSS
$1.01B
$84K ﹤0.01%
716
GNL icon
1707
Global Net Lease
GNL
$1.85B
$83.7K ﹤0.01%
8,143
BIBL icon
1708
Inspire 100 ETF
BIBL
$503M
$83.6K ﹤0.01%
2,541
+1,061
+72% +$33K
NUVL
1709
DELISTED
Nuvalent
NUVL
$83.5K ﹤0.01%
1,981
+550
+38% +$20.8K
CRK icon
1710
Comstock Resources
CRK
$4.13B
$83.3K ﹤0.01%
7,181
NABL icon
1711
N-able
NABL
$650M
$83.3K ﹤0.01%
5,779
+665
+13% +$9.21K
SABR icon
1712
Sabre
SABR
$900M
$83.3K ﹤0.01%
26,098
VRDN icon
1713
Viridian Therapeutics
VRDN
$2.5B
$82.9K ﹤0.01%
3,485
+459
+15% +$11.8K
TCBK icon
1714
TriCo Bancshares
TCBK
$1.84B
$82.9K ﹤0.01%
2,496
WMK icon
1715
Weis Markets
WMK
$1.76B
$82.8K ﹤0.01%
1,290
WABC icon
1716
Westamerica Bancorp
WABC
$1.38B
$82.8K ﹤0.01%
2,161
+207
+11% +$8.28K
ICHR icon
1717
Ichor Holdings
ICHR
$2.66B
$82.5K ﹤0.01%
2,200
FMAR icon
1718
FT Vest US Equity Buffer ETF March
FMAR
$1.16B
$82.1K ﹤0.01%
2,305
+1,965
+578% +$67.4K
CIR
1719
DELISTED
CIRCOR International, Inc
CIR
$82.1K ﹤0.01%
1,454
-215
-13% -$7.54K
PDBC icon
1720
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.66B
$82K ﹤0.01%
6,029
DON icon
1721
WisdomTree US MidCap Dividend Fund
DON
$4.13B
$82K ﹤0.01%
1,950
WRBY icon
1722
Warby Parker
WRBY
$3.2B
$81.9K ﹤0.01%
7,002
+742
+12% +$8.45K
PLYM
1723
DELISTED
Plymouth Industrial REIT
PLYM
$81.7K ﹤0.01%
3,548
+691
+24% +$14.8K
HLX icon
1724
Helix Energy Solutions
HLX
$1.54B
$81.6K ﹤0.01%
11,058
ALK icon
1725
Alaska Air
ALK
$5.13B
$81.5K ﹤0.01%
1,533
-280
-15% -$12.7K

Similar funds

Ameritas Investment Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Ameritas Investment Partners held 3,322 positions worth $2.66B, up 5.3% from $2.53B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Ameritas Investment Partners's Q2 2023 filing shows 317 new, 715 increased, 701 reduced and 212 closed positions. Its largest new stake was Principal Active High Yield ETF: 392,866 shares worth $7.21M. The largest sale was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $6.03M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2023 buy was Principal Active High Yield ETF: 392,866 shares worth $7.21M.
  • Ameritas Investment Partners added most to iShares Core US Aggregate Bond ETF in Q2 2023, an estimated $2.58M increase.
  • Ameritas Investment Partners's biggest Q2 2023 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $6.03M.
  • Ameritas Investment Partners fully exited Victoria's Secret in Q2 2023, selling an estimated $717K.
  • Ameritas Investment Partners's ten largest holdings make up 21% of its $2.66B portfolio in Q2 2023.
  • Ameritas Investment Partners opened 317 new positions and closed 212 in Q2 2023.
  • Ameritas Investment Partners's portfolio value rose 5.3% quarter-over-quarter to $2.66B.

Based on Ameritas Investment Partners's 13F filing for Q2 2023, filed 11 Aug 2023.